Bourne Lent Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.14M | Sell |
|
|||||
2025
Q1 | $8.24M | Sell |
|
|||||
2024
Q4 | $8.35M | Sell |
|
|||||
2024
Q3 | $8.13M | Sell |
|
|||||
2024
Q2 | $6.59M | Sell |
|
|||||
2024
Q1 | $8.82M | Sell |
|
|||||
2023
Q4 | $8.63M | Sell |
|
|||||
2023
Q3 | $10.7M | Sell |
|
|||||
2023
Q2 | $13.2M | Sell |
|
|||||
2023
Q1 | $14.6M | Sell |
|
|||||
2022
Q4 | $15.2M | Sell |
|
|||||
2022
Q3 | $20.9M | Sell |
|
|||||
2022
Q2 | $22.7M | Sell |
|
|||||
2022
Q1 | $21.7M | Sell |
|
|||||
2021
Q4 | $20M | Sell |
|
|||||
2021
Q3 | $21.6M | Hold |
|
|||||
2021
Q2 | $24.4M | Sell |
|
|||||
2021
Q1 | $24.4M | Sell |
|
|||||
2020
Q4 | $24.4M | Sell |
|
|||||
2020
Q3 | $24.8M | Sell |
|
|||||
2020
Q2 | $24.6M | Sell |
|
|||||
2020
Q1 | $23.4M | Sell |
|
|||||
2019
Q4 | $27.1M | Buy |
|
|||||
2019
Q3 | $376K | Sell |
|
|||||
2019
Q2 | $355K | Sell |
|
|||||
2019
Q1 | $383K | Hold |
|
|||||
2018
Q4 | $417K | Buy |
|
|||||
2018
Q3 | $355K | Hold |
|
|||||
2018
Q2 | $317K | Sell |
|
|||||
2018
Q1 | $469K | Hold |
|
|||||
2017
Q4 | $455K | Sell |
|
|||||
2017
Q3 | $479K | Sell |
|
|||||
2017
Q2 | $436K | Hold |
|
|||||
2017
Q1 | $425K | Hold |
|
|||||
2016
Q4 | $457K | Buy |
|
|||||
2016
Q3 | $392K | Hold |
|
|||||
2016
Q2 | $535K | Hold |
|
|||||
2016
Q1 | $464K | Hold |
|
|||||
2015
Q4 | $500K | Hold |
|
|||||
2015
Q3 | $430K | Hold |
|
|||||
2015
Q2 | $484K | Sell |
|
|||||
2015
Q1 | $540K | Buy |
|